These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 34144024

  • 1. The anti-inflammatory effect of ε-viniferin by specifically targeting formyl peptide receptor 1 on human neutrophils.
    Liao HR, Lin CH, Chen JJ, Liu FC, Tseng CP.
    Chem Biol Interact; 2021 Aug 25; 345():109490. PubMed ID: 34144024
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The anti-inflammatory effect of 2-(4-hydroxy-3-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol by targeting Lyn kinase in human neutrophils.
    Liao HR, Chien CR, Chen JJ, Lee TY, Lin SZ, Tseng CP.
    Chem Biol Interact; 2015 Jul 05; 236():90-101. PubMed ID: 25980585
    [Abstract] [Full Text] [Related]

  • 4. 2',3-dihydroxy-5-methoxybiphenyl suppresses fMLP-induced superoxide anion production and cathepsin G release by targeting the β-subunit of G-protein in human neutrophils.
    Liao HR, Chen IS, Liu FC, Lin SZ, Tseng CP.
    Eur J Pharmacol; 2018 Jun 15; 829():26-37. PubMed ID: 29601810
    [Abstract] [Full Text] [Related]

  • 5. 5-Hydroxy-7-methoxyflavone inhibits N-formyl-L-methionyl-L-leucyl-L-phenylalanine-induced superoxide anion production by specific modulate membrane localization of Tec with a PI3K independent mechanism in human neutrophils.
    Liao HR, Chen JJ, Chien YH, Lin SZ, Lin S, Tseng CP.
    Biochem Pharmacol; 2012 Jul 15; 84(2):182-91. PubMed ID: 22484311
    [Abstract] [Full Text] [Related]

  • 6. Larixol inhibits fMLP-induced superoxide anion production and chemotaxis by targeting the βγ subunit of Gi-protein of fMLP receptor in human neutrophils.
    Liao HR, Kao YY, Leu YL, Liu FC, Tseng CP.
    Biochem Pharmacol; 2022 Jul 15; 201():115091. PubMed ID: 35569521
    [Abstract] [Full Text] [Related]

  • 7. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Nagano C, Azuma A, Ishiyama H, Sekiguchi K, Imagawa K, Kikuchi M.
    J Pharmacol Exp Ther; 2001 Apr 15; 297(1):388-94. PubMed ID: 11259567
    [Abstract] [Full Text] [Related]

  • 8. 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,7-dimethoxy-4H-chromen-4-one (MSF-2) suppresses fMLP-mediated respiratory burst in human neutrophils by inhibiting phosphatidylinositol 3-kinase activity.
    Liao CH, Chen JJ, Lin JE, Liu CH, Tseng CP, Day YJ.
    J Cell Physiol; 2011 Jun 15; 226(6):1519-30. PubMed ID: 20945388
    [Abstract] [Full Text] [Related]

  • 9. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL, Karlsson J, Wennerås C, Bylund J, Fu H, Dahlgren C.
    Biochem Pharmacol; 2007 Oct 01; 74(7):1050-6. PubMed ID: 17692291
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E.
    Wenzel-Seifert K, Seifert R.
    J Immunol; 1993 May 15; 150(10):4591-9. PubMed ID: 8387097
    [Abstract] [Full Text] [Related]

  • 11. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K, Grünbaum L, Seifert R.
    J Immunol; 1991 Sep 15; 147(6):1940-6. PubMed ID: 1653806
    [Abstract] [Full Text] [Related]

  • 12. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils.
    Stenson WF, Mehta J, Spilberg I.
    Biochem Pharmacol; 1984 Feb 01; 33(3):407-12. PubMed ID: 6142713
    [Abstract] [Full Text] [Related]

  • 13. Splitomicin inhibits fMLP-induced superoxide anion production in human neutrophils by activate cAMP/PKA signaling inhibition of ERK pathway.
    Liu FC, Day YJ, Liou JT, Yu HP, Liao HR.
    Eur J Pharmacol; 2012 Aug 05; 688(1-3):68-75. PubMed ID: 22634165
    [Abstract] [Full Text] [Related]

  • 14. Expression of annexin-1 in equine leucocytes and the effects of the N-terminal annexin-1 peptide, Ac2-26, on equine neutrophil superoxide production.
    Pickles KJ, Brooks AC, Rickards KJ, Cunningham FM.
    Vet Immunol Immunopathol; 2010 Jun 15; 135(3-4):226-33. PubMed ID: 20079938
    [Abstract] [Full Text] [Related]

  • 15. Estradiol inhibits fMLP-induced neutrophil migration and superoxide production by upregulating MKP-2 and dephosphorylating ERK.
    Zhang P, Fu Y, Ju J, Wan D, Su H, Wang Z, Rui H, Jin Q, Le Y, Hou R.
    Int Immunopharmacol; 2019 Oct 15; 75():105787. PubMed ID: 31401382
    [Abstract] [Full Text] [Related]

  • 16. Bioactive secondary metabolites of a marine Bacillus sp. inhibit superoxide generation and elastase release in human neutrophils by blocking formyl peptide receptor 1.
    Yang SC, Lin CF, Chang WY, Kuo J, Huang YT, Chung PJ, Hwang TL.
    Molecules; 2013 Jun 03; 18(6):6455-68. PubMed ID: 23736784
    [Abstract] [Full Text] [Related]

  • 17. Cyclic AMP-increasing agents interfere with chemoattractant-induced respiratory burst in neutrophils as a result of the inhibition of phosphatidylinositol 3-kinase rather than receptor-operated Ca2+ influx.
    Ahmed MU, Hazeki K, Hazeki O, Katada T, Ui M.
    J Biol Chem; 1995 Oct 06; 270(40):23816-22. PubMed ID: 7559558
    [Abstract] [Full Text] [Related]

  • 18. Investigation of the cellular mechanism of inhibition of formyl-methionyl-leucyl-phenylalanine-induced superoxide anion generation in rat neutrophils by 2-benzyloxybenzaldehyde.
    Wang JP, Chang LC, Lin YL, Hsu MF, Chang CY, Huang LJ, Kuo SC.
    Biochem Pharmacol; 2003 Apr 01; 65(7):1043-51. PubMed ID: 12663040
    [Abstract] [Full Text] [Related]

  • 19. Design and synthesis of tryptophan containing dipeptide derivatives as formyl peptide receptor 1 antagonist.
    Hwang TL, Hung CH, Hsu CY, Huang YT, Tsai YC, Hsieh PW.
    Org Biomol Chem; 2013 Jun 14; 11(22):3742-55. PubMed ID: 23629449
    [Abstract] [Full Text] [Related]

  • 20. The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptide receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists.
    Karlsson J, Fu H, Boulay F, Bylund J, Dahlgren C.
    Biochem Pharmacol; 2006 May 14; 71(10):1488-96. PubMed ID: 16549058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.